LIN SUE-JEAN - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 24, 2025, LIN SUE-JEAN's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Director, and currently has 52,007 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ARQT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

LIN SUE-JEAN - Insider Non-Derivative Transactions of ARQT Common Stock

LIN SUE-JEAN - Insider Non-Derivative Transactions at ARQT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 25, 2025	Sell -- (Common Stock)	25272	30.78	26735
Nov 25, 2025	M -- (Common Stock)	18052	8.63	44787
Nov 25, 2025	M -- (Common Stock)	7220	7.51	52007
Jun 13, 2025	Acquisition -- (Common Stock)	7609	0	26735
Jun 15, 2024	Acquisition -- (Common Stock)	10139	0	19126
Jun 1, 2023	Acquisition -- (Common Stock)	4375	0	8987